Sputum colour is regarded as a good marker of bacterial involvement in acute exacerbations of chronic obstructive pulmonary disease (COPD) and guides many physicians in deciding on antibiotic treatment. Although most doctors rely on the sputum colour that is reported by patients, it can also be assessed using a validated colour chart. In this study, reported sputum colour and assessed sputum colour were compared as markers of the presence of bacteria, bacterial load, and systemic inflammation. Data on 257 exacerbations in 216 patients hospitalized with an acute exacerbation were analysed (mean age, 72 years; mean forced expiratory volume in 1 s, 44.8% + or - 17.8% (+ or - standard deviation)). Sputum colour was reported by the patients and assessed at the laboratory with a colour chart. Subsequently, quantitative sputum cultures were performed. C-reactive protein was measured as a marker of systemic inflammation. A sputum sample was obtained in 216 exacerbations (84%), of which 177 (82%) were representative. A pathogen was identified in 155 patients (60%). Assessed sputum colour was a better marker of the presence of bacteria (OR 9.8; 95% CI 4.7-20.4; p <0.001) than reported sputum colour (OR 1.7; 95% CI 1.0-3.0; p 0.041). The sensitivity and specificity were 73% and 39% for reported sputum colour, and 90% and 52% for assessed sputum colour. Assessed sputum colour was clearly related to sputum bacterial load and C-reactive protein levels, whereas reported sputum colour was not. It is concluded that sputum colour reported by patients is an unreliable marker of the presence of bacteria in acute exacerbations of COPD. Assessed sputum colour is clearly superior and is also related to bacterial load and systemic inflammation.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1469-0691.2009.02892.xDOI Listing

Publication Analysis

Top Keywords

sputum colour
28
colour reported
12
reported patients
12
presence bacteria
12
sputum
9
marker presence
8
acute exacerbations
8
exacerbations chronic
8
chronic obstructive
8
obstructive pulmonary
8

Similar Publications

Article Synopsis
  • - A stage 4 HIV-infected patient presented with severe swelling and proteinuria, indicating potential kidney problems, but kidney biopsy ruled out typical HIV-related kidney disease.
  • - The patient was treated with a combination of medications, leading to initial clinical improvement, but later developed pneumonia and chose not to be hospitalized.
  • - This case highlights the need for more research on kidney diseases associated with HIV, aiming to improve management recommendations for affected individuals.
View Article and Find Full Text PDF

Half of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are caused by bacterial infection, but self-management plans (SMPs) generally advocate use of antibiotics and steroids for all events. We report findings from a qualitative study exploring the acceptability of a sputum colour chart and SMP to guide patient use of antibiotics and steroids (commonly termed a 'rescue pack'). Qualitative interviews were conducted with healthcare professionals (HCPs) and patients from the Colour COPD trial - a randomised controlled trial of usual care (SMP alone) versus usual care plus sputum colour chart to manage AECOPD across England and sampled to promote maximum variation.

View Article and Find Full Text PDF

A clinical entity that was reported less than ten years ago, bronchial anthracofibrosis is marked by multifocal bronchial lumen constriction and anthracotic coloring of the bronchial mucosa. There is various etiology associated with "black bronchoscopy". A 47-year-old woman with no known co-morbidities reported having a three-month history of coughing up sputum.

View Article and Find Full Text PDF

Biological and genomic analyses of , a novel potential fungal pathogen closely related to (syn. ) and .

New Microbes New Infect

December 2024

Shanghai Institute of Infectious Disease and Biosecurity, Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai, PR China.

Article Synopsis
  • - A new species of fungus, identified from a COVID-19 patient's sputum, has been discovered, belonging to the genus *Candida*.
  • - This novel species is closely related to other known fungal pathogens but shows notable genetic differences and chromosomal rearrangements compared to them.
  • - Although it does not thrive at human body temperature, it has been found to increase in lung tissue during a mouse infection model, suggesting it may act as an opportunistic pathogen.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!